Jyong Biotech MENS
NASDAQ MENS
$1.74 -0.05 (-2.79%)
At close: Nov 11, 2026 · 4:00 PM EST

Jyong Biotech (MENS) Buildings (2024 - 2025)

Updated

Jyong Biotech (MENS) reported Buildings of $148,000 for the quarter ended Dec 31, 2025, up 4.2% from $142,000 a year earlier.

Analysis

Jyong Biotech (MENS) Buildings (2024 - 2025) Analysis & Trends

  • By year, Buildings came in at $142,000 in the year ended Dec 31, 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Jyong Biotech 136.09 Mn 134.91 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 2.44 Mn
Dec 31, 2024 2.33 Mn
API Access

Jyong Biotech Buildings API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=buildings&ticker=MENS&period=max&api_key=YOUR_API_KEY